...
首页> 外文期刊>African Journal of Pharmacy and Pharmacology >Evaluation of antitumour action of Ganoderma lucidum extract in hepatocarcinoma mice
【24h】

Evaluation of antitumour action of Ganoderma lucidum extract in hepatocarcinoma mice

机译:灵芝提取物对肝癌小鼠抗肿瘤作用的评价

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The present study shows the protective effects of the?Ganoderma lucidum?aqueous crude extract (GLE) against mice liver cancer. The mice were randomized into four groups, namely, controls and tumor bearers that were?G. lucidum?extract- treated or untreated. Tumor bearers were inoculated intraperitoneally (ip) with 108 Yoshida AH-130 ascites hepatoma cells, whereas the controls received saline alone. The treatment began 1 day after tumor cell inoculation, and continued for 14 days. Administration of?G. lucidum?extract reduced the tumour weight of?G. lucidum-treated groups in a dose dependent way (1.627 ± 0.135, 1.142 ± 0.144 versus 2.163 ± 0.316) as compared to model control group. The inhibition rate was 24.84, and 47.31 by?G. lucidum?extract administration at concentrations of 200 and 400 mg/kg body weight, respectively. Results of this investigation justify continuing with further studies of?G. lucidum?extract components to develop chemoprevention strategies as an option in the treatment of cancer.
机译:本研究表明灵芝水提取物(GLE)对小鼠肝癌的保护作用。将小鼠随机分为四组,即对照组和肿瘤携带者。透明处理或未处理。腹膜内(ip)用108吉田AH-130腹水肝癌细胞接种肿瘤携带者,而对照组仅接受生理盐水。肿瘤细胞接种后1天开始治疗,并持续14天。 G.的管理灵芝提取物减轻了?G的肿瘤重量。与模型对照组相比,非标治疗组的剂量依赖性(1.627±0.135、1.142±0.144和2.163±0.316)。抑制率分别为24.84和47.31。灵芝提取物的给药浓度分别为200和400 mg / kg体重。这项研究的结果证明继续进行G的进一步研究是合理的。灵芝提取成分以开发化学预防策略,作为癌症治疗的一种选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号